Savage et al., 2024 - Google Patents
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitisSavage et al., 2024
View HTML- Document ID
- 6145853884500526959
- Author
- Savage T
- Fortson K
- de Los Santos-Alexis K
- Oliveras-Alsina A
- Rouanne M
- Rae S
- Gamarra J
- Shayya H
- Kornberg A
- Cavero R
- Li F
- Han A
- Haeusler R
- Adam J
- Schwabe R
- Arpaia N
- Publication year
- Publication venue
- Immunity
External Links
Snippet
Production of amphiregulin (Areg) by regulatory T (Treg) cells promotes repair after acute tissue injury. Here, we examined the function of Treg cells in non-alcoholic steatohepatitis (NASH), a setting of chronic liver injury. Areg-producing Treg cells were enriched in the …
- 210000003289 regulatory T cell 0 title abstract description 278
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savage et al. | Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis | |
| Wang et al. | Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | |
| Li et al. | TCR transgenic mice reveal stepwise, multi-site acquisition of the distinctive fat-Treg phenotype | |
| Gong et al. | Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment | |
| Cortes et al. | RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis | |
| Liu et al. | Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma | |
| Li et al. | Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesity | |
| Zhang et al. | STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth | |
| Guay et al. | Lymphocyte-derived exosomal microRNAs promote pancreatic β cell death and may contribute to type 1 diabetes development | |
| Wang et al. | Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3 | |
| Jou et al. | An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation–driven intestinal tumorigenesis | |
| Lee et al. | Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-β during murine colitis | |
| Wagner et al. | Stage-specific requirement for Eomes in mature NK cell homeostasis and cytotoxicity | |
| Corthay et al. | Primary antitumor immune response mediated by CD4+ T cells | |
| Sato et al. | CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade | |
| Gardner et al. | Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4+ T cells | |
| Nasr et al. | Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule | |
| Petkau et al. | The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins | |
| Kanemaru et al. | Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages | |
| Sanctuary et al. | miR-106a deficiency attenuates inflammation in murine IBD models | |
| Effern et al. | Adoptive T cell therapy targeting different gene products reveals diverse and context-dependent immune evasion in melanoma | |
| Bedard et al. | Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells | |
| Xiao et al. | Tregs in visceral adipose tissue up-regulate circadian-clock expression to promote fitness and enforce a diurnal rhythm of lipolysis | |
| Polesso et al. | Constitutive expression of NF-κB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production | |
| Huang et al. | Neutrophils regulate humoral autoimmunity by restricting interferon-γ production via the generation of reactive oxygen species |